CANCER DISCOVERY
Absract - aacrjournals.
Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity Matthew R. Strickland ; Christopher Alvarez-Breckenridge ; Justin F. Gainor; Priscilla K. Brastianos
Review - April 08 2022
"Figure 5. Role of microglia and bone marrow–derived macrophages in BrM..
6. BrM have been shown to have enriched PI3K signaling activity and that PI3K is a master regulator of
metastasis-promoting microglia/macrophages. PI3K is an attractive therapeutic target with a growing list of CNS-penetrant inhibitors available such as GDC-0084".
https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-21-0976/694321/Tumor-Immune-Microenvironment-of-Brain-Metastases#.YlKuYdo4cDU.twitter
Data news from Priscilla K. Brastianos regarding paxalisib (GDC-0084) has been limited for some time.
Open the link and download the PDF for full details of the abstract.
Note: Initial interim data from paxalisib phase II brain metastases study with Alliance for Clinical Trials in Oncology 1H CY2022
Regards.
- Forums
- ASX - By Stock
- KZA
- Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity
Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online